Evdokia Mandala
Overview
Explore the profile of Evdokia Mandala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jacobs J, Stanek C, Booth G, Symeonidis A, Shih A, Allen E, et al.
Am J Hematol
. 2024 Aug;
99(11):2063-2074.
PMID: 39136282
Prior studies have suggested that immune thrombotic thrombocytopenic purpura (iTTP) may display seasonal variation; however, methodologic limitations and sample sizes have diminished the ability to perform a rigorous assessment. This...
2.
Verrou E, Papageorgiou S, Bouzani M, Sevastoudi A, Triantafyllou T, Daiou A, et al.
Hematol Oncol
. 2024 Aug;
42(5):e3303.
PMID: 39105590
Involvement of female genital track (FGT) by diffuse large B cell lymphoma (DLBCL) represents an extremely rare diagnosis. Especially data regarding early-stage disease (i.e., IE, IIE) is very limited. Importantly,...
3.
Venou T, Vetsiou E, Varelas C, Daniilidis A, Psarras K, Koravou E, et al.
J Pers Med
. 2024 Apr;
14(4).
PMID: 38673014
Preeclampsia is a progressive multi-systemic disorder characterized by proteinuria, critical organ damage, and new-onset hypertension. It can be further complicated by HELLP syndrome (hemolysis, elevated liver enzymes, low platelets), resulting...
4.
Mandala E, Lafara K, Kokkinovasilis D, Kalafatis I, Koukoulitsa V, Katodritou E, et al.
Life (Basel)
. 2024 Apr;
14(4).
PMID: 38672794
Applied cardio-oncology in hematological malignancies refers to the integration of cardiovascular care and management for patients with blood cancer, particularly leukemia, lymphoma, and multiple myeloma. Hematological cancer therapy-related cardiotoxicity deals...
5.
Gavriilaki E, Nikolousis E, Koravou E, Dimou-Besikli S, Kartsios C, Papakonstantinou A, et al.
Front Med (Lausanne)
. 2023 Oct;
10:1226114.
PMID: 37901415
Given the limited real-world data of caplacizumab, our multicenter real-world study was designed to assess the safety and efficacy of caplacizumab in immune thrombotic thrombocytopenic pupura (iTTP), compared to historic...
6.
Ouranidis A, Vavilis T, Mandala E, Davidopoulou C, Stamoula E, Markopoulou C, et al.
Biomedicines
. 2022 Jan;
10(1).
PMID: 35052730
In the quest for a formidable weapon against the SARS-CoV-2 pandemic, mRNA therapeutics have stolen the spotlight. mRNA vaccines are a prime example of the benefits of mRNA approaches towards...
7.
Dimou M, Papageorgiou S, Stavroyianni N, Katodritou E, Tsirogianni M, Kalpadakis C, et al.
Hematol Oncol
. 2021 Feb;
39(3):336-348.
PMID: 33583077
Transplant-ineligible relapsed/refractory (rr) diffuse large B-cell lymphoma (DLBCL) patients represent an unmet medical need. Polatuzumab vedotin (Pola), an anti-CD79b antibody-drug-conjugate (ADG), with bendamustine- rituximab(BR) has recently gained approval for these...
8.
Vetsiou E, Mpouras V, Nikolaidou C, Klonizakis P, Mandala E, Vamvakis K, et al.
Hemoglobin
. 2020 Jul;
44(3):221-223.
PMID: 32605400
Necrobiosis lipoidica (NL) is a rare granulomatous disease that predominantly affects middle-aged women and is often associated with diabetes mellitus (DM), rheumatoid arthritis (RA) and other metabolic disorders. Thalassemias are...
9.
Demosthenous C, Vlachaki E, Apostolou C, Eleftheriou P, Kotsiafti A, Vetsiou E, et al.
Hematology
. 2019 Apr;
24(1):426-438.
PMID: 30947625
Objectives: Beta-thalassemias are a group of recessively autosomal inherited disorders of hemoglobin synthesis, which, due to mutations of the beta-globin gene, lead to various degrees of defective beta-chain production, an...
10.
Hadjiaggelidou C, Mandala E, Terpos E, Yiannaki E, Markala D, Triantafyllou T, et al.
Ann Hematol
. 2019 Mar;
98(6):1457-1466.
PMID: 30895351
The exact role of regulatory T cells (Tregs) in multiple myeloma (MM) has not been yet determined. Data regarding alterations of Tregs during therapy with novel agents (NA), i.e., bortezomib...